Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
暂无分享,去创建一个
Ruben Abagyan | Ling Wang | Ronen Marmorstein | Glen Liszczak | Andrew Orry | Cecilia Larocca | R. Abagyan | A. Orry | L. Mahadevan | P. Cole | R. Marmorstein | Marc A. Holbert | R. Alani | D. Meyers | C. A. Hazzalin | H. Yuan | G. Liszczak | Philip A Cole | Chandrani Mukherjee | Hua Yuan | David J Meyers | Yan Sun | Rhoda M Alani | Yan Sun | Marc A Holbert | S. Saldanha | C. Larocca | S Adrian Saldanha | Erin M Bowers | Gai Yan | Nicholas T Crump | Catherine A Hazzalin | Louis C Mahadevan | Chandrani Mukherjee | Ling Wang | Nicholas T. Crump | E. Bowers | Gai Yan | N. Crump
[1] M. Mann,et al. Global and site-specific quantitative phosphoproteomics: principles and applications. , 2009, Annual review of pharmacology and toxicology.
[2] R. Krishna,et al. Post-translational modification of proteins. , 1993, Advances in enzymology and related areas of molecular biology.
[3] Ruben Abagyan,et al. Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. , 2007, Journal of medicinal chemistry.
[4] J. Workman,et al. Characterization of the Yeast Trimeric-SAS Acetyltransferase Complex* , 2005, Journal of Biological Chemistry.
[5] Simon C Watkins,et al. Current Protocols In Cytometry , 1997 .
[6] Ruben Abagyan,et al. Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands. , 2009, Journal of medicinal chemistry.
[7] R. Kitz,et al. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. , 1962, The Journal of biological chemistry.
[8] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[9] Tapas K. Kundu,et al. Small Molecule Modulators of Histone Acetyltransferase p300* , 2003, Journal of Biological Chemistry.
[10] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[11] Timothy W. Sikorski,et al. The Human Monocytic Leukemia Zinc Finger Histone Acetyltransferase Domain Contains DNA-binding Activity Implicated in Chromatin Targeting* , 2007, Journal of Biological Chemistry.
[12] P. Cole,et al. Transcriptional Coactivator Protein p300 , 2001, The Journal of Biological Chemistry.
[13] A. Pandey,et al. Chemical Rescue of a Mutant Enzyme in Living Cells , 2006, Science.
[14] David A. Band,et al. Sas4 and Sas5 Are Required for the Histone Acetyltransferase Activity of Sas2 in the SAS Complex* , 2003, The Journal of Biological Chemistry.
[15] S. Agrawal,et al. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules. , 2009, Journal of medicinal chemistry.
[16] R. Goodman,et al. CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.
[17] P. Cole,et al. Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. , 2008, Current opinion in structural biology.
[18] E. Seto,et al. Lysine acetylation: codified crosstalk with other posttranslational modifications. , 2008, Molecular cell.
[19] S. Agrawal,et al. Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin* , 2009, The Journal of Biological Chemistry.
[20] M. J. Barratt,et al. Phosphoacetylation of histone H3 on c‐fos‐ and c‐jun‐associated nucleosomes upon gene activation , 2000, The EMBO journal.
[21] M. J. Barratt,et al. The nucleosomal response associated with immediate‐early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG‐14 kinase , 1999, The EMBO journal.
[22] Thomas A. Halgren,et al. Merck molecular force field. IV. conformational energies and geometries for MMFF94 , 1996, J. Comput. Chem..
[23] R. Roeder,et al. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. , 2000, Molecular cell.
[24] B. Shoichet,et al. High-throughput assays for promiscuous inhibitors , 2005, Nature chemical biology.
[25] J. Yates,et al. A Fasting Inducible Switch Modulates Gluconeogenesis Via Activator-Coactivator Exchange , 2008, Nature.
[26] J. Denu,et al. A continuous, nonradioactive assay for histone acetyltransferases. , 2000, Analytical biochemistry.
[27] Claudio N. Cavasotto,et al. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. , 2008, Journal of medicinal chemistry.
[28] H. Haisma,et al. Histone acetyl transferases as emerging drug targets. , 2009, Drug discovery today.
[29] J. Blanchard,et al. Bisubstrate inhibition: Theory and application to N-acetyltransferases. , 2006, Biochemistry.
[30] M. Endo,et al. Dantrolene analogues revisited: general synthesis and specific functions capable of discriminating two kinds of Ca2+ release from sarcoplasmic reticulum of mouse skeletal muscle. , 2003, Bioorganic & medicinal chemistry.
[31] J. Licht,et al. Histone Acetyltransferase Activity of p300 Is Required for Transcriptional Repression by the Promyelocytic Leukemia Zinc Finger Protein , 2004, Molecular and Cellular Biology.
[32] Robert A. Copeland,et al. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis , 1996 .
[33] R. Abagyan,et al. De novo discovery of serotonin N-acetyltransferase inhibitors. , 2007, Journal of medicinal chemistry.
[34] G. Wilson,et al. Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive binding. , 1991, Biochemical pharmacology.
[35] L. Mahadevan,et al. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation , 2007, The EMBO journal.
[36] Ronen Marmorstein,et al. Structure of the GCN5 histone acetyltransferase bound to a bisubstrate inhibitor , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[38] P. Cole,et al. p300/CBP-associated Factor Histone Acetyltransferase Processing of a Peptide Substrate , 2000, The Journal of Biological Chemistry.
[39] E. Olson,et al. The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.
[40] Ling Wang,et al. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator , 2008, Nature.
[41] R Abagyan,et al. Flexible protein–ligand docking by global energy optimization in internal coordinates , 1997, Proteins.
[42] Ronen Marmorstein,et al. Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP , 2008, Nature Structural &Molecular Biology.
[43] C. Bolm,et al. Highly modular synthesis of C1-symmetric aminosulfoximines and their use as ligands in copper-catalyzed asymmetric Mukaiyama-aldol reactions. , 2005, Chemistry.
[44] P. Cole,et al. Chemical probes for histone-modifying enzymes. , 2008, Nature chemical biology.
[45] R. Evans,et al. Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.
[46] Andrew J. Bannister,et al. The CBP co-activator is a histone acetyltransferase , 1996, Nature.
[47] B. Howard,et al. The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.
[48] Ruben Abagyan,et al. Derivation of sensitive discrimination potential for virtual ligand screening , 1999, RECOMB.
[49] R. Marmorstein,et al. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design , 2007, Oncogene.
[50] C. Allis,et al. Extraction, purification and analysis of histones , 2007, Nature Protocols.
[51] R. Roeder,et al. Regulation of the p300 HAT domain via a novel activation loop , 2004, Nature Structural &Molecular Biology.
[52] S. M. Ramsh,et al. Synthesis of 1,4-Dihydropyrano[2,3-c]pyrazole Derivatives , 2005 .
[53] Yukihiro Itoh,et al. Isoform-selective histone deacetylase inhibitors. , 2008, Current pharmaceutical design.
[54] Andrew J. Bannister,et al. p300 is required for orderly G1/S transition in human cancer cells , 2007, Oncogene.
[55] Peter J. Alaimo,et al. Recent advances in chemical approaches to the study of biological systems. , 2001, Annual review of cell and developmental biology.
[56] Minoru Yoshida,et al. [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[57] N. Desroy,et al. Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[58] M. Mann,et al. Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.
[59] Andrew J. Bannister,et al. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity , 2005, Molecular Cancer Therapeutics.
[60] T. Kundu,et al. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. , 2007, Chemistry & biology.
[61] Udaykumar Ranga,et al. Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription* , 2004, Journal of Biological Chemistry.
[62] H. Scheraga,et al. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides , 1994 .
[63] P. Cole,et al. Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor. , 2005, Journal of the American Chemical Society.
[64] Y.‐S. Lee,et al. Peptide Synthesis with Polymer Bound Active Ester. Part 2. Synthesis of Pyrazolone Resin and Its Application in Acylation Reaction , 1992 .